Spruce Biosciences (SPRB) stock Forecast for 2021 – 2025

Spruce Biosciences (SPRB) stock Forecast for 2022 – 2026

Last update: 05-28-2022, 9:22

Sector: Healthcare

The share price of Spruce Biosciences, Inc. (SPRB) now

What analysts predict:: $9.17

52-week high/low: $15.08 / $1.25

50/200 Day Moving Average: $1.859 / $3.801

This figure corresponds to the average price over the previous 50/200 days. For Spruce Biosciences stocks, the 50-day moving average is the resistance level today.

For Spruce Biosciences stocks, the 200-day moving average is the resistance level today.

Are you interested in Spruce Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Spruce Biosciences stock price in 2022, 2023, 2024, 2025, 2026. How much will one Spruce Biosciences share be worth in 2022 - 2026?

When should I take profit in Spruce Biosciences stock? When should I record a loss on Spruce Biosciences stock? What are analysts' forecasts for Spruce Biosciences stock? What is the future of Spruce Biosciences stock?

We forecast Spruce Biosciences stock performance using neural networks based on historical data on Spruce Biosciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Spruce Biosciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Spruce Biosciences shares. This happens once a day.




Historical and forecast chart of Spruce Biosciences stock

The chart below shows the historical price of Spruce Biosciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Spruce Biosciences stock price can be found in the table below.

Long-term forecasts by years.

Spruce Biosciences daily forecast for a month

Date Target Pes. Opt. Vol., %
May 30 1.50 1.46 1.55 6.17
May 31 1.52 1.48 1.58 6.96
Jun 01 1.56 1.53 1.58 3.30
Jun 02 1.59 1.53 1.61 5.47
Jun 03 1.60 1.54 1.65 7.06
Jun 04 1.56 1.50 1.60 6.25
Jun 05 1.57 1.51 1.65 9.26
Jun 06 1.57 1.55 1.60 3.36
Jun 07 1.65 1.63 1.71 4.80
Jun 08 1.65 1.63 1.71 4.94
Jun 09 1.68 1.66 1.70 2.68
Jun 10 1.66 1.63 1.72 5.63
Jun 11 1.74 1.69 1.79 6.30
Jun 12 1.78 1.71 1.84 7.65
Jun 13 1.81 1.77 1.87 5.63
Jun 14 1.80 1.73 1.88 8.10
Jun 15 1.76 1.69 1.83 8.35
Jun 16 1.75 1.68 1.79 7.07
Jun 17 1.71 1.65 1.76 6.81
Jun 18 1.65 1.59 1.73 8.79
Jun 19 1.62 1.59 1.69 6.18
Jun 20 1.62 1.58 1.69 6.77
Jun 21 1.64 1.61 1.70 5.75
Jun 22 1.61 1.59 1.65 3.71
Jun 23 1.67 1.62 1.73 6.99
Jun 24 1.65 1.58 1.68 6.52
Jun 25 1.65 1.58 1.67 5.48
Jun 26 1.68 1.66 1.71 3.10
Jun 27 1.66 1.60 1.68 5.11
Jun 28 1.66 1.61 1.71 6.31

Spruce Biosciences Daily Price Targets


Spruce Biosciences Stock Forecast 05-30-2022.

Forecast target price for 05-30-2022: $1.50. Positive dynamics for Spruce Biosciences shares will prevail with possible volatility of 5.812%.

Pessimistic target level: 1.46

Optimistic target level: 1.55


Spruce Biosciences Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $1.52. Positive dynamics for Spruce Biosciences shares will prevail with possible volatility of 6.511%.

Pessimistic target level: 1.48

Optimistic target level: 1.58


Spruce Biosciences Stock Forecast 06-01-2022.

Forecast target price for 06-01-2022: $1.56. Positive dynamics for Spruce Biosciences shares will prevail with possible volatility of 3.192%.

Pessimistic target level: 1.53

Optimistic target level: 1.58


Spruce Biosciences Stock Forecast 06-02-2022.

Forecast target price for 06-02-2022: $1.59. Positive dynamics for Spruce Biosciences shares will prevail with possible volatility of 5.190%.

Pessimistic target level: 1.53

Optimistic target level: 1.61


Spruce Biosciences Stock Forecast 06-03-2022.

Forecast target price for 06-03-2022: $1.60. Positive dynamics for Spruce Biosciences shares will prevail with possible volatility of 6.594%.

Pessimistic target level: 1.54

Optimistic target level: 1.65


Spruce Biosciences Stock Forecast 06-04-2022.

Forecast target price for 06-04-2022: $1.56. Negative dynamics for Spruce Biosciences shares will prevail with possible volatility of 5.884%.

Pessimistic target level: 1.50

Optimistic target level: 1.60


SPRB (SPRB) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 1.30 1.20 1.35 10.82
Jul. 1.46 1.40 1.53 8.28
Aug. 1.45 1.31 1.52 13.63
Sep. 1.27 1.12 1.33 15.96
Oct. 1.26 1.12 1.36 17.55
Nov. 1.33 1.22 1.51 18.82
Dec. 1.35 1.24 1.48 16.61

Spruce Biosciences forecast for this year


Spruce Biosciences Stock Prediction for Jun 2022

An downtrend is forecast for this month with an optimal target price of $1.30181. Pessimistic: $1.20. Optimistic: $1.35


Spruce Biosciences Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $1.46115. Pessimistic: $1.40. Optimistic: $1.53


Spruce Biosciences Stock Prediction for Aug 2022

An downtrend is forecast for this month with an optimal target price of $1.44624. Pessimistic: $1.31. Optimistic: $1.52


Spruce Biosciences Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $1.27414. Pessimistic: $1.12. Optimistic: $1.33


Spruce Biosciences Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $1.25681. Pessimistic: $1.12. Optimistic: $1.36


Spruce Biosciences Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $1.33373. Pessimistic: $1.22. Optimistic: $1.51


Spruce Biosciences Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $1.35413. Pessimistic: $1.24. Optimistic: $1.48




Spruce Biosciences (SPRB) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 1.31 1.24 1.42 12.69
Feb 1.35 1.27 1.46 13.43
Mar 1.35 1.26 1.43 12.03
Apr 1.18 1.10 1.29 14.46
May 1.02 0.95 1.08 12.35
Jun 1.10 1.05 1.16 9.85
Jul 1.27 1.19 1.36 12.95
Aug 1.45 1.32 1.63 19.33
Sep 1.59 1.41 1.80 21.46
Oct 1.64 1.58 1.74 9.13
Nov 1.64 1.54 1.74 11.21
Dec 1.86 1.74 1.99 12.42

Spruce Biosciences (SPRB) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 1.60 1.41 1.77 20.21
Feb 1.73 1.65 1.90 13.00
Mar 1.64 1.58 1.79 11.99
Apr 1.40 1.35 1.46 7.66
May 1.53 1.40 1.62 13.34
Jun 1.59 1.52 1.74 12.61
Jul 1.62 1.56 1.77 11.97
Aug 1.59 1.53 1.75 12.98
Sep 1.53 1.47 1.66 11.61
Oct 1.59 1.50 1.69 10.88
Nov 1.70 1.49 1.80 17.01
Dec 1.67 1.59 1.85 14.26



Spruce Biosciences (SPRB) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 1.78 1.62 1.96 17.49
Feb 1.89 1.79 2.09 14.26
Mar 1.92 1.68 2.08 19.46
Apr 2.20 2.05 2.39 14.37
May 2.54 2.30 2.72 15.37
Jun 2.76 2.40 3.02 20.68
Jul 2.84 2.66 2.95 9.67
Aug 2.66 2.48 2.90 14.50
Sep 2.29 2.16 2.47 12.30
Oct 1.95 1.74 2.04 14.60
Nov 1.83 1.71 1.93 10.96
Dec 1.74 1.63 1.83 10.69

Spruce Biosciences (SPRB) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 1.71 1.65 1.81 8.68
Feb 1.69 1.58 1.78 11.00
Mar 1.58 1.51 1.72 12.59
Apr 1.61 1.48 1.70 13.18
May 1.85 1.66 1.93 14.19
Jun 2.13 2.04 2.23 8.28
Jul 2.29 2.12 2.59 18.19
Aug 2.37 2.07 2.50 17.22
Sep 2.32 2.07 2.57 19.38
Oct 2.30 2.10 2.55 17.48
Nov 2.41 2.25 2.73 17.54
Dec 2.25 1.97 2.52 21.88

Spruce Biosciences information and performance

The company has developed a candidate product, tildaserfont, as the first potential non-steroidal therapy for the treatment of congenital adrenal hyperplasia. Congenital adrenal hyperplasia belongs to the group of hereditary diseases. People have two adrenal glands, each located at the top of each kidney. These glands produce the hormones cortisol and aldosterone, which play an important role in the body. People with congenital hyperplasia of the adrenal cortex do not synthesize the enzyme necessary for the production of hormones.

Spruce Biosciences Address

2001 JUNIPERO SERRA BLVD., SUITE 640, DALY CITY, CA, US

Market Capitalization: 31 715 400 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.886

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: 1.216

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 23492900

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.